Abstract:Abstract Background Globally, antimicrobial resistance has become one of the most complex public health challenges. Accurate estimates of health and economic burden of antimicrobial resistance has not been available in China because of the absence of representative empirical data. We therefore aimed to estimate the effect of antimicrobial resistance attributable to Staphylococcus aureus bloodstream infections in Chinese hospitals, and to compare the effect of resistant strains with susceptible strains. Methods We did a multicentre, retrospective cohort study of 11 tertiary hospitals in China. The cohort consisted of all inpatients with S aureus bloodstream infections from the sample hospitals, and we randomly included individuals free of S aureus bloodstream infections. We stratified the patients into two categories of S aureus bloodstream infections: meticillin-susceptible S aureus (MSSA) or meticillin-resistant S aureus (MRSA). The primary outcome was the effect of antimicrobial resistance on excess length of stay in the hospital, hospital mortality, and cost of treatment. We adopted a multistate model to estimate the expected length of stay. Multi-level Cox proportional hazards models were adopted to compare the hazard of reaching hospital death, discharge alive, and the combined end-of-stay endpoint. Two bed-day values were adopted when estimating the cost of treatment. This study was approved by Peking University Health Science Center Ethics Committee, with a waiver for individual informed consent. Findings From Jan 1, 2010, to June 31, 2017, we assessed 861 inpatients with S aureus bloodstream infections and 10 000 individuals free of S aureus bloodstream infections. Of the 861 admissions with an S aureus blood stream infection detected, 324 (38%) were due to MRSA and 537 (62%) were due to MSSA. Bloodstream infections caused by MRSA prolonged the length of stay in the hospital by 13·4 days (95% CI 11·1–16·3), and MSSA bloodstream infections prolonged the length of stay by 11·9 days (95% CI 9·7–14·1). However, bloodstream infections caused by MRSA did not increase the hazard of death (adjusted hazard ratio [aHR] 0·31, 95% CI 0·09–1·10). MSSA bloodstream infections also did not increase the hazard of death (aHR 0·59, 95% CI 0·14–2·54). Compared with MSSA, MRSA did not significantly increase the hazard of death (aHR 0·44, 95% CI 0·19–1·03), excess length of stay (1·5 days, 95% CI −0·4 to 2·8), and cost of treatment. Although the cost of MRSA treatment was higher per infection than MSSA treatment, the annual cost of MSSA was higher overall. Interpretation By accounting for time-dependent bias and important confounders, this study added to the existing literature about the effect of antimicrobial resistance in China. Current results of the study implicate the importance of surveillance and infection control policies that target infections rather than resistance. Funding China Medical Board (17-270).

Percutaneous coronary intervention versus coronary bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: The VA AWESOME multicenter registry: comparison with the randomized clinical trial.

Active Surveillance of Carbapenem-Resistant Gram-Negative Bacteria to Guide Antibiotic Therapy: a Single-Center Prospective Observational Study

Role of hormones in mammary neoplasia.

Mortality Associated with Third Generation Cephalosporin-Resistance in Enterobacteriaceae Infections: a Multicenter Cohort Study in Southern China.

[Patients of Escherichia Coli Bloodstream Infection: Analysis of Antibiotic Resistance and Predictors of Mortality].

Multidrug-resistant bacterial infections in cirrhotic patients: an epidemiological study.

Clinical and economic burden of bloodstream infections caused by meticillin-resistant and meticillin-susceptible Staphylococcus aureus in Chinese tertiary hospitals from 2010 to 2017: a multicentre, retrospective cohort study

Free fatty acid inhibition of alpha-glycerophosphate dehydrogenase activity in rat brain.

Risk Factors for Acquisition and Mortality of Multidrug-Resistant Acinetobacter Baumannii Bacteremia

PMU28 CLINICAL AND ECONOMIC OUTCOMES OF CARBAPENEM-RESISTANT GRAM-NEGATIVE ORGANISMS: A MULTICENTER STUDY IN CHINA

OP115 Effect of Multiple Drug Resistance on Costs for Patients with Intra-Abdominal Infections in China

Mortality, Length of Stay, and Healthcare Costs Associated With Multidrug-Resistant Bacterial Infections Among Elderly Hospitalized Patients in the United States

Absence of periodontitis in a population of insulin-dependent diabetes mellitus (IDDM) patients.

The attributable mortality, length of stay, and health care costs of methicillin-resistant Staphylococcus aureus infections in Singapore

Impact of multidrug resistance on outcomes in hematologic cancer patients with bacterial bloodstream infections

A retrospective longitudinal observational study of natural history of ESBL/MDR gram negative organisms in patients hospitalized in a tertiary hospital

Risk factors for bacteremia and mortality due to multidrug-resistant Acinetobacter baumannii : a retrospective study

Long-Term Outcomes of Multidrug-Resistant Pseudomonas aeruginosa Bacteriuria: A Retrospective Cohort Study

Studies in the biochemistry of micro-organisms; a survey of fungal metabolism of inorganic sulphates.

[Lactate dehydrogenase isoenzymes in acute pulmonary diseases].

Incidence, antimicrobial resistance and mortality of Pseudomonas aeruginosa bloodstream infections among hospitalized patients in China: a retrospective observational multicenter cohort study from 2017 to 2021